Amanote Research
Register
Sign In
A Novel Form of Receptor Interaction May Contribute to -Agonist Resistance in Asthma
Thorax
- United Kingdom
doi 10.1136/thx.2006.la0215
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
August 1, 2006
Authors
G Warwick
Publisher
BMJ
Related search
Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia
PLoS ONE
Multidisciplinary
The Prorenin Receptor and Its Soluble Form Contribute to Lipid Homeostasis
Exploration of a Novel Adjuvant Therapeutic Regimen Using a Potent Glucocorticoid Receptor Agonist Along With iNOS Inhibitor in Murine Model of Asthma
International Journal of Research in Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
Indacaterol, a Novel Inhaled 2-Agonist, Provides Sustained 24-H Bronchodilation in Asthma
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma
Respiratory Medicine
Pulmonary
Respiratory Medicine
Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population
Clinical Pharmacology and Therapeutics
Pharmacology
Calpain May Contribute to Hereditary Cataract Formation in Sheep
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Mitonuclear Interactions May Contribute to Fitness of Fungal Hybrids
Scientific Reports
Multidisciplinary
The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid a Augments Innate Host Resistance to Systemic Bacterial Infection
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
